Gastro-intestinal complications as one of causes of death in patients with rheumatic diseases
https://doi.org/10.14412/1995-4484-2005-614
Abstract
References
1. <div><p>ЗайратьянцО.В. Анализ смертности, летальности, числаау- топсий и качества клинической диагностики в Москве за последнее десятилетие (1991-2000). М., 2002</p><p>Fries J. Non-steroidal anli-inflammatory drug safety: a view from the ARAMIS databank. Curr. Opin. Rheumat. 1996, 9, 3-7.</p><p>Hawkey CJ. Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut, 2002, 50 (suppl. 3), 1125 - 1130</p><p>Шостак H.A., Рябкова A.A., Савельев B.C., Малярова Л.Н. Желудочно-кишечное кровотечение как осложнение гастропатий, связанных с приемом нестероидных противовоспалительных препаратов. Тер. архив, 2003, 5, 70-74</p><p>Laporte J., Ibanez L., Vidal X. et al. Uppergastrointestinal bleeding associated with the use of NSAI Ds: newer versus older / agents. Drug Saf., 2004, 27, 411-420</p><p>Menniti-Ippolito F., Maggini М., Raschetti R. et al. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non steroidal anti-inflammatory drugs in Italy. Eur. J. Clin. Pharmacol., 1998, 54, 393-397</p><p>Garcia Rodriguez LA., Cattaruzzi C., Troncon M.G., Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other NSAIDs, calcium antagonists, and other antihypertensive drugs. Arch. Intern. Med., 1998, 158, 33-39</p><p>Lipworth L., Friis S., Blot W.J. et al. A population-based cohort study of mortality among users of ibuprofen in Denmark. Am. J. Ther., 2004, 11, 156-163</p></div><br />
Review
For citations:
Sorotskaya V.N., Karateev A.E. Gastro-intestinal complications as one of causes of death in patients with rheumatic diseases. Rheumatology Science and Practice. 2005;43(4):34-37. (In Russ.) https://doi.org/10.14412/1995-4484-2005-614